NL-OMON22050尚未招募不适用
Pilot Study of BB3 to Improve Renal Function in Patients with Signs and Symptoms of Significant Renal Injury after Kidney Transplantation from Donors after Cardiac Death.
Angion Biomedica Europe LimitedAngion Biomedica Corp.1050 Stewart AvenueGarden City, NY 115300 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subjects must sign the informed consent document prior to performance of any study related procedure including the Screening procedure;
- •2. Males and females ≥ 18 years of age;
排除标准
- •1. Mean arterial pressure <40 mmHg or cardiac index <1.8 L/min/m2;
- •2. Requires emergency dialysis for reasons other than high plasma creatinine levels, e.g. severe fluid overload or severe metabolic abnormalities;
研究者
相似试验
已完成
2 期
Pilot Study of BB3 to Improve Renal Function in Patients with Signs and Symptoms of Significant Renal Injury after Kidney Transplantation from Donors after Cardiac DeathDelayed graft function1002914910038365NL-OMON39114Angion Biomedica Corp.18
进行中（未招募）
1 期
Exploratory Study of BB3 to Improve Renal Function in Patients with Signs and Symptoms of Significant Renal Injury after Kidney Transplantation from Donors after Cardiac DeathEUCTR2010-019243-19-GBAngion Biomedica Corp.36
撤回
2 期
Pilot Study of BB3 to Improve Renal Function in Patients with Signs and Symptoms of Significant Renal Injury after Kidney Transplantation from Donors after Cardiac Death.NL-OMON32550Angion Biomedica Corp.30
进行中（未招募）
不适用
Exploratory Study of BB3 to Improve Renal Function in Patients with Signs and Symptoms of Significant Renal Injury after Kidney Transplantation from Donors after Cardiac DeathPatients suffering from end-stage renal disease, receiving a donor kidney from donors after cardiac deathMedDRA version: 17.0Level: LLTClassification code 10014647Term: End stage renal failureSystem Organ Class: 100000004857EUCTR2010-019243-19-ESAngion Biomedica Corp.36
Unknown
2 期
Study on Delayed Graft Function Using Paired KidneysDelayed Graft FunctionNCT01561599Angion Biomedica Corp12